Your browser doesn't support javascript.
loading
X-linked Inhibitor of Apoptosis (XIAP) Deficiency Complicated by Hemophagocytic Lymphohistiocytosis on Immunotherapy Leading to Acute Respiratory Distress Syndrome and Multiorgan Failure Secondary to Opportunistic Infections.
Kim, David; Liu, Stephanie; Zolotov, Eli; Padalkar, Roma.
Afiliación
  • Kim D; Internal Medicine, Hackensack University Medical Center, Hackensack, USA.
  • Liu S; Family Medicine, JFK University Medical Center, Edison, USA.
  • Zolotov E; Internal Medicine, Hackensack University Medical Center, Hackensack, USA.
  • Padalkar R; Internal Medicine, Hackensack University Medical Center, Hackensack, USA.
Cureus ; 16(6): e62703, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38912075
ABSTRACT
X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency with a broad spectrum of clinical manifestations, including susceptibility to hemophagocytic lymphohistiocytosis (HLH), inflammatory bowel disease (IBD), hypogammaglobulinemia, and severe infections. We present a case of a 39-year-old male with a past medical history of XIAP deficiency complicated by HLH, Crohn's disease, and hypogammaglobulinemia, who developed acute respiratory distress syndrome (ARDS) due to Pneumocystis jiroveci pneumonia (PJP) and concurrent multiorgan failure due to disseminated Mycobacterium avium intracellulare (MAI) infection. This case highlights the challenges in managing XIAP deficiency, emphasizing the importance of early recognition, and the need for further research to improve outcomes in this population.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos